Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2026.05.26
CHANGE OF EMPLOYEE REPRESENTATIVE DIRECTORS
2026.05.26
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2026.05.26
POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING
2026.05.26
ag真人平台官方：2025年度股东会决议公告
2026.05.26
ag真人平台官方：第七届董事会第一次会议决议公告
2026.05.26
ag真人平台官方：关于董事会完成换届选举及聘任高级管理人员、证券事务代表的公告
2026.04.29
CIRCULAR OF 2025 ANNUAL GENERAL MEETING
2026.04.29
PROXY FORM FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS
2026.04.29
NOTICE OF ANNUAL GENERAL MEETING
2026.04.29
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
